Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline – Xconomy
|
Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline
Xconomy The Medtronic deal is part of Acorda's grand plan to build up its Phase 2 pipeline of drugs to address unmet medical needs in neurology. The fast-growing company already has two marketed products—dalfampridine (Ampyra) to treat multiple sclerosis, … |
Short URL: http://trends-medical.com/?p=440
Posted by admin
on Jul 1 2011. Filed under DRUGS & SUPPLEMENTS.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.